Balan et al. found that cytoplasmic COX-2 immunostaining intensity was weaker in specimens with low-grade squamous intraepithelial lesions (LSIL) and stronger in those diagnosed with high-grade squamous intraepithelial lesion (HSIL) [5]. Here, PTGS2 is linked to squamous cell intraepithelial neoplasia.